Cure My Disease

Don't miss your cure!

 Log in / Sign up

A personalized clinic may help advanced cancer patients feel better

NCT ID NCT06465511

Symptom relief Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests a supportive clinic for people living with advanced or metastatic cancer. Participants receive personalized feedback and advice on managing symptoms, diet, physical activity, and psychosocial issues from a multidisciplinary team. The study compares this to a self-management pamphlet approach. The goal is to see if this clinic is feasible and acceptable, and whether it can reduce symptom distress and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Supportive clinic with personalized feedback and multidisciplinary advice
What this could lead to
If this works, it could point toward a practical way to ease symptoms and improve quality of life for people living with advanced cancer.
What could go wrong
This is a small feasibility study, so it may not show clear benefits. The intervention is complex and may be hard to deliver consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with advanced or metastatic cancer * are at least 18 years of age * physically able to attend the supportive clinic. Exclusion Criteria: * Participants will be excluded from the study if they are non-Cantonese-, non-Mandarin-, or non-English-speakers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Physical symptom distress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Center of Cancer Medicine, Queen Mary Hospital

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

  • JCICC

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Obstetrics & Gynaecology

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Oncology

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Surgery

    RECRUITING

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.